Studies showed that centrally-acting ACE inhibitors (mainly captopril) can retard the development of neurodegeneration and even reduce cognitive decline25, 28, while non-centrally-acting ACE inhibitors reportedly increase the risk of dementia by 73% in older hypertensive adults25. Here, ACE is linked to dementia.